Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed that it attached a Press Release on December 10, 2021 titled ‘SPARC to present updated clinical data of vodobatinib (SCO-088) at the 63rd ASH annual meeting’.
The above information is a part of company’s filings submitted to BSE.